Transcription of 032-2008: Clinical-Data Acceptance Testing Procedure - SAS
{{id}} {{{paragraph}}}
Example: bankruptcy
032-2008: Clinical-Data Acceptance Testing Procedure - SAS
1 Paper 032-2008 Clinical-Data Acceptance Testing Procedure Sunil Gupta, Quintiles, Thousand Oaks, CA ABSTRACT In the pharmaceutical industry, there is a regulatory responsibility, 21 CFR Part 11, to analyze only the clinical data that has passed data Acceptance Testing or is considered clean data after a database lock. clinical data Acceptance Testing Procedure involves confirming the validity of critical data variables. These critical data variables might need to be non-missing, consist only of valid values, be within a range, or be consistent with other variables. If incorrect clinical data is analyzed, then invalid study conclusions can be drawn about the drug s safety and efficacy.
Feb 04, 2008 · 1 Paper 032-2008 Clinical-Data Acceptance Testing Procedure Sunil Gupta, Quintiles, Thousand Oaks, CA ABSTRACT In the pharmaceutical industry, there is a regulatory responsibility, 21 CFR Part 11, to analyze only the clinical data
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Data quality, Using SAS to Move Data betweenServers, Using SAS® to Move Data betweenServers, Data, To Move Data between Servers, SAS: Proc GPLOT, Getting Started with ArcGIS, White Paper May, 2011 Zeliade Systems, NORTH CAROLINA TREATMENT OUTCOMES AND, North carolina treatment outcomes and program performance